Brought to you by:
SCVS Young Vascular Surgeons Program deadline further extended
The deadline for applications to the 2026 Society for Clinical Vascular Surgery (SCVS) Young Vascular Surgeons Program has been further extended to Jan. 4 at 11:59 p.m. Eastern Time. Designed for early-career vascular surgeons who have completed fellowships or an…
Deadline extended for SCVS Young Surgeons Program
The application deadline for the Society for Clinical Vascular Surgery (SCVS) 2026 Young Vascular Surgeons Program has been extended until midnight Eastern Time on Sunday (Dec. 14). The program will take place as part of the 2026 SCVS Annual Symposium…
Unionization for vascular surgeons: Are you ready to join?
Vascular Specialist readers may wonder why I am now raising this topic amid current challenges facing vascular surgery, like governmental concerns, low reimbursement, specialty competition, the involvement of advanced practice providers without direct affiliation with vascular surgeons, and discussions regarding…
Survey suggests greater exposure to mini-incision carotid endarterectomy during training may dispel perceived limitations to approach
While a recent survey found that a majority of those who responded had performed mini-incision carotid endarterectomy (CEA) at least once in their practice careers, most answered that they did not perform the surgery routinely. In the world of general…
Equivalent outcomes seen among female, male patients in real-world analysis of paclitaxel-eluting stent use
The use of a paclitaxel-eluting stent to treat femoropopliteal occlusive disease led to equivalent outcomes in male and female patients in “a diverse and complex real-world cohort,” a new study found, set against previous question marks over the effectiveness of…
New study validates BEST-CLI trial results, ‘suggesting generalizability’
A new propensity-matched analysis of more than 1,100 lower extremity revascularization procedures carried out in patients with chronic limb-threatening ischemia (CLTI)—which aimed to help solve the puzzle of why the BEST-CLI trial did not lead to a pick-up in the…
‘The leader must own everything in his or her world, own every mistake and credit the team for successes’
“We can almost be considered a specialty of colonizers, acquiring borrowed techniques. Why, then, do we see ourselves as the keepers of vascular care? Why do we think that we are the ones that can deliver the best vascular care?…
SCVS 2025: Rowe becomes SCVS president
Vincent Rowe, MD, from the University of California, Los Angeles (UCLA), became the 2025–26 Society for Clinical Vascular Surgery (SCVS) president during the Society’s 52nd Annual Symposium in Austin, Texas (March 29–April 2). Falling in line behind him are Peter…
SCVS 2025: TBE device provides ‘safer’ option than TEVAR for blunt thoracic injuries in setting of zone 2 coverage
Use of the Gore Tag thoracic branch endoprosthesis (TBE) “offers a safer alternative” to traditional thoracic endovascular aortic repair (TEVAR) with left subclavian artery (LSA) coverage in blunt thoracic aortic injury (BTAI) requiring zone 2 coverage for zone 2 or…
SCVS 2025: Multicenter data show favorable role for FEVAR over chimney grafts
A multi-institutional analysis has demonstrated fenestrated endovascular aneurysm repair (FEVAR) could be a “safer and more durable option” than chimney EVAR (ChEVAR) in elective juxtarenal abdominal aortic aneurysm (AAA) cases with suitable anatomy, offering potentially “greater generalizability to real-world practice.”…